These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34479957)

  • 21. Induction of indoleamine-2,3 dioxygenase in bone marrow stromal cells inhibits myeloma cell growth.
    Pfeifer S; Schreder M; Bolomsky A; Graffi S; Fuchs D; Sahota SS; Ludwig H; Zojer N
    J Cancer Res Clin Oncol; 2012 Nov; 138(11):1821-30. PubMed ID: 22722711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the immunosuppressive enzyme indoleamine 2,3-dioxygenase in the progression of ovarian carcinoma.
    Inaba T; Ino K; Kajiyama H; Yamamoto E; Shibata K; Nawa A; Nagasaka T; Akimoto H; Takikawa O; Kikkawa F
    Gynecol Oncol; 2009 Nov; 115(2):185-92. PubMed ID: 19665763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of tryptophan contained in 1-Methyl-Tryptophan on antimicrobial and immunoregulatory functions of indoleamine 2,3-dioxygenase.
    Schmidt SK; Siepmann S; Kuhlmann K; Meyer HE; Metzger S; Pudelko S; Leineweber M; Däubener W
    PLoS One; 2012; 7(9):e44797. PubMed ID: 23028625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of indoleamine 2,3-dioxygenase in testicular immune-privilege.
    Gualdoni GS; Jacobo PV; Sobarzo CM; Pérez CV; Matzkin ME; Höcht C; Frungieri MB; Hill M; Anegon I; Lustig L; Guazzone VA
    Sci Rep; 2019 Nov; 9(1):15919. PubMed ID: 31685866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indoleamine 2,3-Dioxygenase Activity During Acute Toxoplasmosis and the Suppressed T Cell Proliferation in Mice.
    Ufermann CM; Domröse A; Babel T; Tersteegen A; Cengiz SC; Eller SK; Spekker-Bosker K; Sorg UR; Förster I; Däubener W
    Front Cell Infect Microbiol; 2019; 9():184. PubMed ID: 31231617
    [No Abstract]   [Full Text] [Related]  

  • 26. Ganoderic acid Me induces the apoptosis of competent T cells and increases the proportion of Treg cells through enhancing the expression and activation of indoleamine 2,3-dioxygenase in mouse lewis lung cancer cells.
    Que Z; Zou F; Zhang A; Zheng Y; Bi L; Zhong J; Tian J; Liu J
    Int Immunopharmacol; 2014 Nov; 23(1):192-204. PubMed ID: 25138378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses.
    Hou DY; Muller AJ; Sharma MD; DuHadaway J; Banerjee T; Johnson M; Mellor AL; Prendergast GC; Munn DH
    Cancer Res; 2007 Jan; 67(2):792-801. PubMed ID: 17234791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens.
    Engin AB; Engin A
    Adv Exp Med Biol; 2021; 1275():339-356. PubMed ID: 33539022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of immunodominant antitumor and antiviral CD8+ T cell responses by indoleamine 2,3-dioxygenase.
    Rytelewski M; Meilleur CE; Yekta MA; Szabo PA; Garg N; Schell TD; Jevnikar AM; Sharif S; Singh B; Haeryfar SM
    PLoS One; 2014; 9(2):e90439. PubMed ID: 24587363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of indoleamine 2,3-dioxygenase by LPS in a porcine model.
    Wirthgen E; Tuchscherer M; Otten W; Domanska G; Wollenhaupt K; Tuchscherer A; Kanitz E
    Innate Immun; 2014 Jan; 20(1):30-9. PubMed ID: 23606516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of indoleamine 2,3-dioxygenase promotes vascular inflammation and increases atherosclerosis in Apoe-/- mice.
    Polyzos KA; Ovchinnikova O; Berg M; Baumgartner R; Agardh H; Pirault J; Gisterå A; Assinger A; Laguna-Fernandez A; Bäck M; Hansson GK; Ketelhuth DF
    Cardiovasc Res; 2015 May; 106(2):295-302. PubMed ID: 25750192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma.
    Li M; Bolduc AR; Hoda MN; Gamble DN; Dolisca SB; Bolduc AK; Hoang K; Ashley C; McCall D; Rojiani AM; Maria BL; Rixe O; MacDonald TJ; Heeger PS; Mellor AL; Munn DH; Johnson TS
    J Immunother Cancer; 2014; 2():21. PubMed ID: 25054064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment.
    Tanizaki Y; Kobayashi A; Toujima S; Shiro M; Mizoguchi M; Mabuchi Y; Yagi S; Minami S; Takikawa O; Ino K
    Cancer Sci; 2014 Aug; 105(8):966-73. PubMed ID: 24826982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The tryptophan derivative, tranilast, and conditioned medium with indoleamine 2,3-dioxygenase-expressing cells inhibit the proliferation of lymphoid malignancies.
    Suwa S; Kasubata A; Kato M; Iida M; Watanabe K; Miura O; Fukuda T
    Int J Oncol; 2015 Mar; 46(3):1369-76. PubMed ID: 25572287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Indoleamine 2, 3-dioxygenase Up-regulates Hypoxia-inducible Factor-1α Expression by Degrading L-tryptophan but Not Its Activity in Human Alloreactive T-cells.
    Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I
    Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):56-67. PubMed ID: 29512370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of indoleamine 2,3-dioxygenase in human endometrial carcinoma cells induces rapid tumor growth in a mouse xenograft model.
    Yoshida N; Ino K; Ishida Y; Kajiyama H; Yamamoto E; Shibata K; Terauchi M; Nawa A; Akimoto H; Takikawa O; Isobe K; Kikkawa F
    Clin Cancer Res; 2008 Nov; 14(22):7251-9. PubMed ID: 19010841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.
    Maes M; Leonard BE; Myint AM; Kubera M; Verkerk R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):702-21. PubMed ID: 21185346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy.
    Zhai L; Dey M; Lauing KL; Gritsina G; Kaur R; Lukas RV; Nicholas MK; Rademaker AW; Dostal CR; McCusker RH; Raizer JJ; Parsa AT; Bloch O; Wainwright DA
    J Clin Neurosci; 2015 Dec; 22(12):1964-8. PubMed ID: 26279502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of core body temperature on Tryptophan metabolism, kynurenines, and estimated IDO activity in critically ill patients receiving target temperature management following cardiac arrest.
    Schefold JC; Fritschi N; Fusch G; Bahonjic A; Doehner W; von Haehling S; Pschowski R; Storm C; Schroeder T
    Resuscitation; 2016 Oct; 107():107-14. PubMed ID: 27565863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.
    Eleftheriadis T; Pissas G; Antoniadi G; Spanoulis A; Liakopoulos V; Stefanidis I
    Int Immunol; 2014 Dec; 26(12):673-84. PubMed ID: 25064493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.